After Hours Summary: PLAY +6% following guidance, GNW +4% on M&A progressAfter Hours Gainers:
Companies trading higher in after hours in reaction to guidance: PLAY +6%, RBBN +4.7% (light volume)
Companies trading higher in after hours in reaction to news: EXEL +4.5% (announces FDA approval of CABOMETYX tablets for previously treated hepatocellular carcinoma), ARRY +3.7% (announces updated safety and efficacy results from Phase 3 BEACONC CRC trial), GNW +3.8% (Genworth Financial receives approval from New York regulator for proposed Oceanwide transaction), NBEV +3% (ongoing volatility), AGI +2.1% (ticking higher; reports Q4 production with 2019 guidance), FFBC +1.1% (announces stock repurchase plan of up to 5.0 mln shares of common stock)
After Hours Losers:
Companies trading lower in after hours in reaction to guidance: ENR -2% (also commenced concurrent offerings of $187.5 mln of shares of common stock and $187.5 mln of shares of Series A Mandatory Convertible Preferred Stock pursuant to an effective registration statement), CTRN -0.9% (light volume), TTMI -0.6%
Companies trading lower in after hours in reaction to news: ALNY -4.1% (announces 5 mln share offering as part of previously announced shelf offering), STML -3.6% (proposed offering to sell 6.6 mln shares of common stock), ARR -2.7% (commences underwritten public offering of 5 mln shares of common stock), XLRN -1.9% (announces proposed public offering of $200 mln of its common stock)